Status:
COMPLETED
Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia
Lead Sponsor:
University of Pittsburgh
Conditions:
Preeclampsia
Gestational Hypertension
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Preeclampsia causes devastating maternal and neonatal morbidity and mortality with a high recurrence risk and a rapid, occult progression to cardiovascular disease after delivery. There is a critical ...
Detailed Description
The overall objective of this study is to conduct a pilot trial of an internet-based lifestyle intervention and home blood pressure monitoring in the year after delivery among overweight and obese wom...
Eligibility Criteria
Inclusion
- pre-pregnancy body mass index ≥25 kg/m2
- diagnosed with preeclampsia or gestational hypertension
- access to internet
Exclusion
- multiple gestation
- medical co-morbidities: chronic kidney disease, active liver disease (acute hepatitis, chronic active hepatitis), active cardiac disease, pre-pregnancy diabetes mellitus, chronic hypertension diagnosed prior to pregnancy
- pregnancy prior to randomization
Key Trial Info
Start Date :
January 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT03749746
Start Date
January 26 2019
End Date
December 1 2021
Last Update
December 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States, 15213